Clinical Trials · NCT03899077
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Cancer Research Antwerp
- Enrollment
- 202
- Start date
- Apr 2019
- Locations
- 9 sites, Belgium
- Primary endpoint
- EPIC-26 sexual domain score